OTC Casting and Splinting Products

OTC Casting and Splinting Products Market Outlook

The global OTC casting and splinting products market is projected to reach approximately USD 2.5 billion by 2035, exhibiting a CAGR of around 4.8% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing incidence of orthopedic injuries, a rising geriatric population susceptible to fractures and sprains, and the growing demand for advanced orthopedic supplies that ensure better immobilization and support for patients. Furthermore, as healthcare systems evolve, the emphasis on home care and outpatient treatment is driving the demand for over-the-counter (OTC) products, allowing patients to manage their recovery effectively without always needing professional supervision. The advent of innovative materials and design improvements to enhance comfort and durability is also contributing to market expansion. Additionally, the rise of e-commerce platforms has made these products more accessible to consumers, further fueling market growth.

Growth Factor of the Market

The growth of the OTC casting and splinting products market can be attributed to several key factors. Firstly, there is an increasing prevalence of sports-related injuries amongst both amateur and professional athletes, leading to a higher demand for effective treatment solutions like casts and splints. Secondly, the aging population is more prone to accidental falls and age-related bone fragility, contributing to a significant market need for supportive orthopedic products. Thirdly, advancements in material technology have led to the development of lighter, more durable, and comfortable alternatives, driving consumer preference towards innovative product lines. Fourthly, the rise in healthcare awareness and the push for cost-effective treatment options in outpatient settings have encouraged consumers to opt for OTC products. Lastly, the growing trend towards self-care and home treatment has made these products readily available and popular among consumers, thereby significantly enhancing their market presence.

Key Highlights of the Market

• Increasing demand for lightweight and durable casting materials.
• Rising incidence of sports injuries driving product sales.
• Growth in the aging population leading to more orthopedic-related injuries.
• Technological advancements in product design enhancing user comfort and effectiveness.
• Expansion of e-commerce platforms facilitating easier access to OTC products.

By Product Type

Plaster Casts :

Plaster casts have long been a staple in orthopedic care, providing effective immobilization for patients recovering from fractures. Despite the emergence of modern alternatives, plaster casts are still utilized due to their affordability and ease of application. They are particularly favored in low-resource settings and among orthopedic practitioners who appreciate their reliability and familiarity. However, plaster casts are heavier than some newer materials and are susceptible to water damage, which can limit their usability in certain circumstances. Despite these drawbacks, they continue to play a significant role in the market, particularly for patients who require long-term immobilization solutions.

Fiberglass Casts :

Fiberglass casts have become increasingly popular within the OTC casting and splinting products market due to their lightweight and water-resistant properties, making them more comfortable for patients. They offer the same level of immobilization as plaster casts but with enhanced durability and a quicker setting time. This type of cast is particularly beneficial for active patients who require a supportive solution that does not impede their daily activities. The colorful options available also appeal to younger demographics, making treatment more engaging for children. As a result, fiberglass casts are expected to continue gaining market share as consumers seek effective yet user-friendly alternatives.

Polyurethane Casts :

Polyurethane casts represent a niche but growing segment within the OTC casting and splinting products market. These casts are known for their flexibility and superior comfort, allowing for greater mobility while still providing necessary support to the affected area. They can also be waterproof, making them suitable for patients who lead active lifestyles or those who require showering without compromising their treatment. Additionally, polyurethane casts can be more breathable than traditional plaster casts, reducing skin irritation. However, the higher cost associated with these casts may limit their adoption in some healthcare settings, although their benefits may outweigh the costs for many consumers.

Thermoplastic Splints :

Thermoplastic splints have gained traction in the market for their customizable and moldable properties, allowing healthcare providers to create tailored solutions for individual patients. These splints are ideal for various applications, from post-operative support to managing chronic conditions. The ease of application and adjustability make thermoplastic splints particularly favored by both practitioners and patients, as they can be reshaped as needed to accommodate swelling or changes in condition. This flexibility enhances patient comfort and compliance, which is crucial for effective recovery. As awareness of these advantages grows, thermoplastic splints are expected to see a rise in demand.

Prefabricated Splints :

Prefabricated splints are designed for immediate use and convenience, making them a popular option for both medical professionals and consumers. These splints come in various sizes and shapes, catering to a wide range of injuries and conditions. Their ease of use and quick application make them ideal for emergency situations and outpatient settings. As healthcare practices move towards more efficient care delivery systems, the demand for prefabricated splints is likely to rise. They also provide cost-effective solutions for patients who may not have access to custom-made options, thus democratizing access to effective orthopedic support.

By Application

Fractures :

Fractures are one of the most common applications for OTC casting and splinting products. As a leading cause of morbidity worldwide, fractures require prompt immobilization to promote healing and prevent further damage. The range of available casting materials allows for better patient customization and comfort, catering to different types of fractures, including simple and compound fractures. OTC products provide patients with the necessary tools to manage their recovery effectively, ensuring that they can comply with treatment at home. As the incidence of fractures continues to rise, particularly among older adults and active individuals, this application segment remains a cornerstone of the market's growth.

Sprains :

Sprains, particularly in the ankle and wrist, are common injuries that often necessitate the use of splints for support and immobilization. The OTC casting and splinting products market has seen an increase in products designed specifically for sprain management, reflecting the need for accessible treatment options. These products are essential for providing the necessary compression and stabilization to reduce pain and swelling. The availability of lightweight, breathable splints has enhanced patient compliance, making it easier for individuals to manage their injuries while maintaining their daily activities. As the prevalence of sprains rises due to increased participation in sports and fitness activities, this application segment is expected to grow significantly.

Soft Tissue Injuries :

Soft tissue injuries, which include strains, tendon injuries, and ligament damage, are prevalent in both everyday activities and sports. The need for effective immobilization and support during the healing process makes OTC splinting products essential in this application. These products help facilitate recovery by minimizing movement and providing targeted support to the affected area. The growing awareness of sports medicine and the importance of prompt treatment for soft tissue injuries has also contributed to an increase in demand for these products. With the rise of telemedicine and home care options, patients are increasingly turning to OTC solutions to manage their recovery from soft tissue injuries.

Sports Injuries :

Sports injuries encompass a broad range of conditions, from fractures and sprains to more complex soft tissue injuries. This sector of the market has seen significant growth as participation in sports and physical activities has surged globally. Athletes and active individuals require reliable and effective casting and splinting products to support their recovery and allow for a safe return to their activities. The importance of timely intervention for sports injuries has led to an increase in consumer awareness regarding OTC options that provide immediate support. As a result, the market for sports injury-related products is anticipated to expand in line with growing sports participation rates and awareness of injury management.

Others :

This segment encompasses a variety of applications beyond those listed above, including post-surgical support and chronic condition management. The versatility of OTC casting and splinting products allows for their use across a multitude of injury types and healthcare needs. This broad applicability is contributing to the overall growth of the market, as healthcare providers increasingly recommend OTC solutions for a variety of conditions. Additionally, advancements in product design and material technology are enabling the development of specialized products that address unique patient needs, further expanding this segment's scope.

By Distribution Channel

Pharmacies :

Pharmacies play a crucial role in the distribution of OTC casting and splinting products, offering patients immediate access to necessary medical supplies. They serve as convenient points of purchase for consumers who may require products quickly due to acute injuries. The widespread presence of pharmacies, especially in urban areas, facilitates easy access for individuals seeking treatment options without the need for a prescription. As pharmacies expand their offerings and improve in-store visibility for orthopedic products, this channel is expected to see continued growth. The knowledgeable staff in pharmacies can also provide crucial guidance on product selection, further enhancing the customer experience.

Online Retailers :

The e-commerce segment has emerged as a significant channel for distributing OTC casting and splinting products, driven by the increasing trend of online shopping. Online retailers provide consumers with the convenience of browsing a wide selection of products from the comfort of their homes. This method also allows for price comparisons and reviews, empowering consumers to make informed decisions. With the growth of telehealth services, many patients are turning to online platforms for their orthopedic needs, further driving sales in this channel. The ongoing advancements in logistics and delivery services are also improving the overall consumer experience, making online shopping an attractive option for those seeking quick and reliable access to necessary products.

Hospitals & Clinics :

Hospitals and clinics constitute a significant distribution channel for OTC casting and splinting products, particularly for post-operative care and short-term injury management. These healthcare facilities often provide patients with necessary supplies during their visits, ensuring that they leave with appropriate support for their recovery. The relationship between product manufacturers and healthcare providers fosters brand loyalty, as patients are likely to continue using products recommended by their doctors. Moreover, as outpatient care becomes increasingly prevalent, hospitals and clinics are expanding their offerings of OTC products, presenting additional opportunities for market growth within this distribution channel.

Orthopedic Centers :

Orthopedic centers specialize in the treatment of musculoskeletal injuries and conditions, making them vital distribution points for OTC casting and splinting products. These centers often have a comprehensive understanding of their patients' needs and can recommend suitable products tailored to individual recovery plans. As orthopedic practices evolve and become more integrated with outpatient care, the demand for accessible OTC products will likely increase. The specialized knowledge and expertise available at orthopedic centers also encourage patients to seek out these facilities for their casting and splinting needs, further solidifying this channel’s position in the market.

Others :

This category includes various alternative distribution channels, such as specialty medical supply stores, direct-to-consumer brands, and telemedicine platforms. These channels provide valuable access to OTC casting and splinting products, catering to specific consumer preferences and enabling broader market reach. The growth of telemedicine, in particular, has facilitated a greater understanding of patients' needs and preferences, allowing for tailored recommendations and efficient product distribution. As the healthcare landscape continues to evolve, these alternative distribution channels are expected to play an increasingly significant role in the OTC casting and splinting products market.

By Material Type

Plaster of Paris :

Plaster of Paris remains one of the most widely used materials for producing casts due to its affordability and ease of application. It has a long-standing reputation for providing effective immobilization for various fractures. Despite the emergence of modern alternatives, many healthcare providers continue to utilize plaster of Paris for its proven efficacy and familiarity. However, its weight and susceptibility to moisture can present challenges for patients, leading to discomfort and the need for careful handling. Nevertheless, its extensive history and reliable performance ensure that plaster of Paris casting products will continue to occupy a significant share of the market.

Fiberglass :

Fiberglass has revolutionized the OTC casting and splinting products market, offering significant advantages over traditional plaster casts. Known for being lightweight, durable, and water-resistant, fiberglass casts provide patients with an improved experience during recovery. They are easier to apply and set quickly, making them a preferred choice for many healthcare professionals. Additionally, the variety of colors and patterns available can enhance patient compliance, especially among children. As awareness of the benefits of fiberglass over plaster continues to grow, this material segment will likely see increased demand and innovation.

Polyurethane :

Polyurethane is a material utilized in specific casting solutions, offering enhanced flexibility and comfort compared to traditional options. Its ability to provide effective support while accommodating patient movement makes it an attractive choice for individuals requiring a more dynamic orthotic solution. Polyurethane casts can also be designed to be waterproof, appealing to active patients who need to manage their recovery without sacrificing their lifestyle. As the demand for comfortable and functional orthopedic solutions rises, the market for polyurethane products is expected to expand significantly.

Thermoplastic :

Thermoplastic materials are increasingly utilized in the production of splints due to their moldability and versatility. They can be reheated and reshaped to accommodate changes in swelling or patient needs, making them particularly valuable in clinical settings. Thermoplastic splints allow healthcare providers to create customized support solutions that enhance patient comfort and compliance. The ongoing development of advanced thermoplastic materials is likely to drive market growth, as these products continue to evolve and adapt to a range of orthopedic applications.

By Region

The regional analysis of the OTC casting and splinting products market reveals significant trends and variations in demand across different geographic areas. North America leads the market, primarily driven by a high prevalence of orthopedic injuries and a well-established healthcare infrastructure. The region is projected to maintain a robust growth rate of around 5% CAGR from 2025 to 2035, fueled by technological advancements and increased adoption of innovative products. Europe follows closely, with demand stimulated by an aging population and increasing participation in sports activities. Countries like Germany and the UK contribute significantly to market growth as they invest in advanced healthcare solutions.

In the Asia Pacific region, the market for OTC casting and splinting products is rapidly expanding, driven by growing awareness of healthcare and the increasing prevalence of injuries due to rising urbanization and active lifestyles. The region is expected to exhibit a CAGR of approximately 6% during the forecast period, bolstered by expanding healthcare systems and increasing disposable income. Latin America and the Middle East & Africa are also witnessing gradual growth, supported by increasing access to healthcare and rising consumer awareness regarding orthopedic treatment options. However, these regions still lag behind North America and Europe in terms of market size and growth potential.

Opportunities

The OTC casting and splinting products market is rife with opportunities for growth and innovation. One of the most significant opportunities lies in the development of advanced materials and technologies that enhance product performance and patient comfort. As healthcare providers and patients increasingly seek lightweight, durable, and waterproof solutions, manufacturers have the chance to invest in research and development to create next-generation products. Embracing emerging technologies, such as 3D printing and smart materials, could enable the production of customized casts and splints tailored to individual patient needs, thus improving compliance and recovery outcomes. Additionally, the growing trend of telemedicine and remote consultations creates an opportunity for manufacturers to collaborate with healthcare providers to ensure that patients have easy access to necessary products through online platforms.

Furthermore, expanding into emerging markets presents a substantial growth opportunity for OTC casting and splinting products. Regions experiencing rapid urbanization and increasing healthcare investments, such as Asia Pacific and Latin America, offer potential for market expansion. Local partnerships and distribution networks can facilitate market entry and help gain market share in these areas. Education and awareness campaigns regarding the importance of proper injury management and recovery can also drive demand for OTC products. By leveraging these opportunities, industry players can enhance their market presence and establish themselves as leaders in the global OTC casting and splinting products market.

Threats

The OTC casting and splinting products market is not without its challenges, and several threats could impact its growth trajectory. One significant threat arises from the availability of counterfeit and substandard products, which can undermine consumer confidence and pose risks to patient safety. With the rise of e-commerce platforms, the risk of encountering low-quality products has increased, leading to potential complications in injury management. Regulatory challenges and stringent compliance standards can also hinder market entry for new players, limiting competition and innovation. Additionally, the healthcare industry's shift towards minimally invasive treatments and advanced orthopedic interventions may result in a reduced reliance on traditional casting and splinting methods, affecting overall demand.

Another threat is the economic variability in certain regions, which may affect consumer spending on healthcare products. During economic downturns, patients may prioritize essential treatments over OTC products, leading to a decline in sales. Furthermore, the growing emphasis on self-care and the availability of alternative treatments may lead to patients opting for non-conventional methods instead of traditional casting and splinting products. As the market evolves, addressing these threats through enhanced quality control measures, education, and market adaptation will be crucial for sustaining growth and establishing consumer trust.

Competitor Outlook

• 3M Company
• Smith & Nephew plc
• BSN Medical GmbH
• Medtronic plc
• DeRoyal Industries, Inc.
• Zimmer Biomet Holdings, Inc.
• Allard International
• Orthofix International N.V.
• Acumed LLC
• Integra LifeSciences Corporation
• Hollister Incorporated
• Medline Industries, Inc.
• Futuro (a subsidiary of 3M Company)
• Kanghui Medical Equipment Co., Ltd.
• Ranfac Corp.

The competitive landscape of the OTC casting and splinting products market is characterized by a mix of established players and emerging companies striving to capture market share through innovation and strategic positioning. Major companies like 3M Company and Smith & Nephew plc are well-known for their extensive product portfolios and strong distribution networks, allowing them to maintain a competitive edge. These companies continuously invest in research and development to enhance product quality and introduce new features, ensuring they meet the evolving needs of consumers and healthcare providers alike. Moreover, the significant resources and brand recognition of these industry leaders provide them with the ability to engage in effective marketing strategies and expand their global footprint.

Emerging players are also making strides in the market by focusing on niche segments and developing specialized products that cater to unique patient needs. Companies like Allard International and Acumed LLC are recognized for their innovative approaches to casting and splinting solutions, emphasizing patient comfort and mobility. These companies are leveraging technological advancements and engaging in strategic collaborations to enhance their product offerings. As competition intensifies, the introduction of advanced materials and customizable solutions will be key differentiators for companies looking to establish themselves as leaders in the market.

Furthermore, the shift in consumer behavior towards online shopping is prompting companies to adapt their distribution strategies to meet changing consumer preferences. Many major players are establishing a robust online presence and partnering with e-commerce platforms to facilitate direct access to their products. This shift enables companies to reach a broader audience and engage with consumers more effectively. Additionally, the increasing focus on sustainability and eco-friendly materials is pushing manufacturers to explore innovative solutions that align with consumer values. As the market landscape evolves, companies that prioritize innovation, sustainability, and consumer engagement will be well-positioned for success in the competitive OTC casting and splinting products market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Acumed LLC
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Ranfac Corp.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 BSN Medical GmbH
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Allard International
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hollister Incorporated
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 DeRoyal Industries, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Medline Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Orthofix International N.V.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Zimmer Biomet Holdings, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Integra LifeSciences Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Futuro (a subsidiary of 3M Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Kanghui Medical Equipment Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 OTC Casting and Splinting Products Market, By Application
    • 6.1.1 Fractures
    • 6.1.2 Sprains
    • 6.1.3 Soft Tissue Injuries
    • 6.1.4 Sports Injuries
    • 6.1.5 Others
  • 6.2 OTC Casting and Splinting Products Market, By Product Type
    • 6.2.1 Plaster Casts
    • 6.2.2 Fiberglass Casts
    • 6.2.3 Polyurethane Casts
    • 6.2.4 Thermoplastic Splints
    • 6.2.5 Prefabricated Splints
  • 6.3 OTC Casting and Splinting Products Market, By Material Type
    • 6.3.1 Plaster of Paris
    • 6.3.2 Fiberglass
    • 6.3.3 Polyurethane
    • 6.3.4 Thermoplastic
  • 6.4 OTC Casting and Splinting Products Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retailers
    • 6.4.3 Hospitals & Clinics
    • 6.4.4 Orthopedic Centers
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 OTC Casting and Splinting Products Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global OTC Casting and Splinting Products market is categorized based on

By Product Type

• Plaster Casts
• Fiberglass Casts
• Polyurethane Casts
• Thermoplastic Splints
• Prefabricated Splints

By Application

• Fractures
• Sprains
• Soft Tissue Injuries
• Sports Injuries
• Others

By Distribution Channel

• Pharmacies
• Online Retailers
• Hospitals & Clinics
• Orthopedic Centers
• Others

By Material Type

• Plaster of Paris
• Fiberglass
• Polyurethane
• Thermoplastic

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Smith & Nephew plc
• BSN Medical GmbH
• Medtronic plc
• DeRoyal Industries, Inc.
• Zimmer Biomet Holdings, Inc.
• Allard International
• Orthofix International N.V.
• Acumed LLC
• Integra LifeSciences Corporation
• Hollister Incorporated
• Medline Industries, Inc.
• Futuro (a subsidiary of 3M Company)
• Kanghui Medical Equipment Co., Ltd.
• Ranfac Corp.